David Mahoney Net Worth & Insider Trades

David Mahoney - Director, Corcept Therapeutics Inc

As of June 2, 2022

What is David Mahoney's Net Worth?

The current estimated net worth of Corcept Therapeutics Inc's Director, David Mahoney, is estimated to be about $4.61M . David Mahoney owns about 1,169,320 units of Corcept Therapeutics Inc common stock. In the last 18 years at Corcept Therapeutics Inc, David Mahoney has sold an estimated value of $576.44K worth.

What is David Mahoney's Past Insider Trading?

David Mahoney's largest purchase order was 200,000 units , worth over $200K on April 3, 2007. David Mahoney's largest sale order was 95,238 units , worth over $200K on August 20, 2007. In total, David Mahoney has made about 29 transactions over 18 years of their time at Corcept Therapeutics Inc. David Mahoney usually trades in June, with the busiest year in 2015 and 2006. The most recent transaction was a sale order of 33,828 units , worth over $194.07K on July 9, 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is David Mahoney's' Mailing Address?

  • Mailing address is Symantec Corporation 20330 Stevens Creek Blvd. Cupertino CA 95014 CA

Corcept Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Joseph K. Belanoff, M.D., 2020 $769,567 $744,000 $4,237,643 $10,892 $5,762,102
Joseph K. Belanoff, M.D., 2019 $707,525 $745,290 $3,506,155 - $4,958,970
Joseph K. Belanoff, M.D., 2018 $679,792 $477,750 $5,157,075 - $6,314,617
Andreas Grauer, M.D., 2020 $454,550 $219,157 $1,271,293 $118,274 $2,063,274
Andreas Grauer, M.D., 2019 $362,267 $243,720 $3,115,335 $78,245 $3,799,567
Hazel Hunt, Ph.D., 2020 $431,873 $243,000 $2,084,640 - $2,759,513
Sean Maduck, 2020 $474,380 $214,157 $2,508,404 - $3,196,941
Sean Maduck, 2019 $456,133 $308,881 $1,476,276 - $2,241,290
Sean Maduck, 2018 $436,667 $198,000 $2,171,400 - $2,806,067
Charles Robb, 2020 $474,380 $321,236 $2,118,822 - $2,914,438
Charles Robb, 2019 $456,133 $308,881 $1,845,345 - $2,610,359
Charles Robb, 2018 $436,667 $237,600 $2,171,400 - $2,845,667
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm

What are Corcept Therapeutics Inc's Past Insider Trades?

Corcept Therapeutics Inc's most recent insider trade came on September 8, 2022 by Gary Charles Robb who sold 50,000 units worth $1.3M . In the last 18 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $194.22M and bought an estimated value of $186.77M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer,  Robert Roe, President and Secretary,  and Leonard Baker Jr, Director .

CORCEPT THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1